Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.
about
Menopausal symptoms in young survivors of breast cancer: a growing problem without an ideal solutionκ Agonists as a novel therapy for menopausal hot flashes.A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7.Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial.Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions.Pilot evaluation of a stellate ganglion block for the treatment of hot flashes.Mindfulness training for coping with hot flashes: results of a randomized trial.A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patientsEscitalopram treatment of menopausal hot flashes.Hot flashes: a review of pathophysiology and treatment modalities.North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.Is complementary and alternative therapy effective for women in the climacteric period?Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study.Androgen deprivation therapy-associated vasomotor symptomsSexual function in nondepressed women using escitalopram for vasomotor symptoms: a randomized controlled trialEffect of escitalopram on hot flash interference: a randomized, controlled trialEffect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trialTreatment options for vasomotor symptoms in menopause: focus on desvenlafaxine.Risk factors, pathophysiology, and treatment of hot flashes in cancer.Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventionsSternal skin conductance: a reasonable surrogate for hot flash measurement?Phase II evaluation of S-adenosyl-L-methionine (SAMe) for the treatment of hot flashes.How well do different measurement modalities estimate the number of vasomotor symptoms? Findings from the Study of Women's Health Across the Nation FLASHES Study.Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.Nonhormonal management of hot flashes for women on risk reduction therapy.Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice.Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations.Hot flushes in women with breast cancer: state of the art and future perspectives.Validity, cut-points, and minimally important differences for two hot flash-related daily interference scales.Duloxetine and escitalopram for hot flushes: efficacy and compliance in breast cancer survivors.Management of Potential Long-Term Toxicities in Breast Cancer Patients.Differences in clinician understanding and management of early menopause after breast cancer.Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study.Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up.
P2860
Q27025094-8B9E0A1A-B084-47FD-BB25-6E47C42F0A32Q30355071-40E64DEB-B317-48F1-9258-D1C459398544Q33451759-7A1C8140-B3B1-47B8-8EBC-22286A0C7465Q33964099-EB6FA6D1-3B1E-45B3-B3B1-2FC1FBF1830CQ34243328-DC45355F-B09D-45D2-BBA2-179C4754FBFBQ34272132-3C884CE1-4B07-4098-9AEF-B635999C58B4Q35022143-86A2BDED-997C-4E85-B003-A4483C27507DQ35068756-97C830DC-698C-4F89-9E84-C5A04C31B717Q35092002-8CD1404A-2184-4A1B-BD58-042DA03B993FQ35234675-F02DFB56-B547-45CB-8B3A-DB47F7E60224Q35599841-31BFE24E-00B0-4645-BADD-0921B91E303BQ35639908-33058F1F-FA9C-4E40-ADF4-5054BE2E9EFAQ35675788-6B02943D-A14E-4900-BA2D-4C2D631D68CAQ35751415-4952D15B-220A-447F-A207-2FC1ABF832A8Q35917204-304DFFD4-78F1-4C34-B272-992548AFC5BBQ35936499-330EB7CE-AD14-4730-8DBF-491C14A9E5DDQ36007860-F13E15DA-C217-406A-9E50-1C29E50D9BB3Q36055178-D7CFFD15-AF26-4497-9C23-FAB7061EAB37Q36136356-0CDC732B-1BA1-4FE1-82FB-B3A73D56394BQ36807455-AFB37C58-35BB-4F94-A2F1-04178FFD00F3Q36818466-79C37977-002E-4972-8BC3-AA0DE49800D9Q37048734-EBF2C0BF-40A3-4AB1-A0B4-C82190DE94A5Q37152016-C5FF4155-610C-4581-83C4-7687157EF785Q37266107-A129E637-6D49-4F67-8CBD-4F0E7FF39730Q37284439-A46F71C6-BBA9-4126-898A-F28747004B34Q37579591-B66ED93D-C143-44F4-A241-3F48154A31F2Q37965541-893A9D69-5494-4F0A-BE58-17C6FDE0F6C2Q38084117-550BA36B-B15F-41B5-800B-7401A7EDFBDBQ38169220-67AAF962-DF86-496B-BBE9-EF17BB9C48C4Q38683235-4BB60072-5E11-4B88-84DC-4CC09BBDE19BQ39175842-77E97D8F-F12E-44F6-9C60-3C506181B172Q39305824-1F9F4D38-A6B3-4BD5-A092-217E726100EFQ44835501-4A74B220-0468-4513-9C61-EF325AF0B995Q47948024-B49DCF0C-BCC5-4C3E-B2C8-050F6226D093Q48218348-6036FDA7-C89E-4BD1-8249-5F3158591053
P2860
Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phase III, placebo-controlled ...... ot flashes: NCCTG trial N05C9.
@ast
Phase III, placebo-controlled ...... ot flashes: NCCTG trial N05C9.
@en
type
label
Phase III, placebo-controlled ...... ot flashes: NCCTG trial N05C9.
@ast
Phase III, placebo-controlled ...... ot flashes: NCCTG trial N05C9.
@en
prefLabel
Phase III, placebo-controlled ...... ot flashes: NCCTG trial N05C9.
@ast
Phase III, placebo-controlled ...... ot flashes: NCCTG trial N05C9.
@en
P2093
P2860
P356
P1476
Phase III, placebo-controlled ...... ot flashes: NCCTG trial N05C9.
@en
P2093
Allen N Stawis
Beth I LaVasseur
Brent Diekmann
Charles L Loprinzi
David B Johnson
Debra L Barton
Jeff A Sloan
Kathleen A Flynn
Missy Dyar
Pamela J Atherton
P2860
P304
P356
10.1200/JCO.2009.26.6379
P407
P577
2010-05-24T00:00:00Z